Submitted by Anonymous (not verified) on 21 November 2024 - 12:19
Opinion/decision on a Paediatric investigation plan (PIP): Dupixent, dupilumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0396/2023
Source: